y 27632 has been researched along with mannose-6-phosphate in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (mannose-6-phosphate) | Trials (mannose-6-phosphate) | Recent Studies (post-2010) (mannose-6-phosphate) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 605 | 1 | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beljaars, L; Gosens, R; Lacombe, M; Poelstra, K; Post, E; Prakash, J; Reker-Smit, C; van Beuge, MM | 1 |
| Beljaars, L; Lacombe, M; Poelstra, K; Post, E; Prakash, J; Reker-Smit, C; van Beuge, MM | 1 |
2 other study(ies) available for y 27632 and mannose-6-phosphate
| Article | Year |
|---|---|
Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
Topics: Amides; Animals; Aorta; Drug Carriers; Hepatic Stellate Cells; Humans; Insulin-Like Growth Factor II; Liver; Liver Cirrhosis; Male; Mannosephosphates; Mice; Mice, Inbred BALB C; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; Serum Albumin | 2011 |
Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
Topics: Amides; Animals; Carbon Tetrachloride Poisoning; Cells, Cultured; Drug Carriers; Enzyme Inhibitors; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mannosephosphates; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pyridines; Rats; Rats, Wistar; Receptor, IGF Type 2; rho-Associated Kinases; Serum Albumin; Tissue Distribution | 2011 |